Brown R D, Cairns J E
Trans Ophthalmol Soc U K (1962). 1983;103 ( Pt 3):297-312.
Dissatisfaction with other forms of treatment in the neovascular and other 'difficult' glaucomas led the authors to use the Molteno long tube implant. This paper resulted from a review of the results obtained in 30 cases over the past four years. The patients fell naturally into the two groups of neovascular and non-neovascular glaucomas. The eyes with neovascular glaucoma had an implant used early in the disease process, while the eyes with non-neovascular glaucoma tended to have the implant used as a last resort, after the failure of conventional techniques. An overall success rate of 63 per cent was found and this could be subdivided into success rates of 50 per cent for the non-neovascular group and of 75 per cent for the neovascular group. These findings probably reflect the late or early use of the implant in the disease process. The results confirm the authors' clinical impression that the Molteno long tube implant is a useful tool in the management of these glaucomas, and that for optimal results it should be considered early in the condition.
由于对新生血管性青光眼和其他“难治性”青光眼的其他治疗方式不满意，作者们采用了莫尔滕诺长管植入物。本文是对过去四年中30例患者的治疗结果进行回顾总结而成。患者自然分为新生血管性青光眼组和非新生血管性青光眼组。新生血管性青光眼患者在疾病早期就植入了该装置，而非新生血管性青光眼患者往往在传统技术失败后才将该植入物作为最后的手段使用。总体成功率为63%，其中非新生血管性青光眼组成功率为50%，新生血管性青光眼组成功率为75%。这些结果可能反映了该植入物在疾病过程中的早晚使用情况。结果证实了作者的临床印象，即莫尔滕诺长管植入物是治疗这些青光眼的一种有用工具，并且为了获得最佳效果，应在病情早期就考虑使用。
